Franklin Resources Inc Seelos Therapeutics, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.65 - $278.68 $694 - $297,630
1,068 Added 1.4%
77,106 $79,000
Q2 2022

Aug 11, 2022
SELL
$0.51 - $0.93 $18,619 - $33,953
-36,509 Reduced 32.44%
76,038 $52,000
Q4 2021

Feb 11, 2022
SELL
$1.59 - $2.38 $720 - $1,078
-453 Reduced 0.4%
112,547 $183,000
Q3 2021

Nov 12, 2021
BUY
$1.69 - $2.89 $190,970 - $326,570
113,000 New
113,000 $272,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email